156.73
Charles River Laboratories International Inc Borsa (CRL) Ultime notizie
Are Wall Street Analysts Bullish on Charles River Laboratories Stock? - inkl
Charles River Laboratories Inte (CRL) Stock Analysis: A 30% Upside Potential Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Cell Banking Outsourcing Market: 16%+ CAGR (2026-2031), Expanding with Rising Demand for Biologics and Regenerative Medicine Services, Says Mordor Intelligence - GlobeNewswire Inc.
Is Charles River (CRL) Quietly Recasting Its Moat Around AI Pathology And Cell Therapy Services? - Yahoo Finance
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Should Higher Impairments and AI Investments Shape a New Capital Allocation Playbook for Charles River (CRL)? - simplywall.st
Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness - simplywall.st
Inspired Announces CFO Transition - The Manila Times
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MSN
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call - Yahoo Finance
Charles River Laboratories Tops Q3 Estimates, Tightens Full-Year Outlook - MSN
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance
Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform - simplywall.st
Charles River (CRL) reliance on international sales: What investors need to know - MSN
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Director Nancy Andrews gifts Charles River (CRL) shares to trust - Stock Titan
Charles River Laboratories stock (US1591881009): Q1 earnings beat with updated FY guidance - AD HOC NEWS
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions - BioSpace
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Charles River Laboratories stock (US1591881009): Shareholders approve 2026 incentive plan - AD HOC NEWS
Charles River Laboratories (CRL) Announces Approval of 2026 Long-Term Incentive Plan - GuruFocus
Director Steven Barg receives 1,438-share equity award at Charles River (NYSE: CRL) - Stock Titan
Charles River Labs (CRL) director receives 1,438-share equity award grant - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,438-share stock grant - Stock Titan
Charles River Laboratories stock (US1591881009): Q1 earnings beat but FY2026 forecast cut - AD HOC NEWS
Number of shareholders of Charles River Laboratories International, Inc. – HAM:RV6 - TradingView
Charles River Laboratories International Inc (CRL) Stock Down 5. - GuruFocus
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down - MSN
Charles River Labs Shareholders Approve New Incentive Plan - TipRanks
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Charles River (NYSE: CRL) investors approve 2026 incentive plan, pay and auditor - Stock Titan
Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors - marketscreener.com
Charles River (NYSE: CRL) director Abraham Ceesay receives 1,438-share stock grant - Stock Titan
Charles River Labs (NYSE: CRL) director Martin Mackay receives new stock grants - Stock Titan
Director at Charles River (NYSE: CRL) gets 1,438-share equity grant - Stock Titan
Charles River (NYSE: CRL) director receives stock grants instead of fees - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,438-share stock award - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,973-share equity award - Stock Titan
Director Virginia M. Wilson (CRL) receives 1,438-share equity award at Charles River - Stock Titan
Director James Foster gets 1,860 Charles River (NYSE: CRL) shares - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Charles River (CRL) Enhances Digital Pathology Platform for Fast - GuruFocus
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow - 01net
Charles River (CRL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Charles River expands AI-enabled digital pathology platform By Investing.com - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):